NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Share Price Crosses Above 200-Day Moving Average - Here's Why

Key Points

• NorthWest Health Prop Real Est Inv Trust's stock price has recently surpassed its 200-day moving average, reaching a high of C$5.11, indicating positive market momentum.
• The company has a market capitalization of C$1.26 billion and is characterized by a high debt-to-equity ratio of 129.42, which may indicate financial risk.
• NorthWest Health provides investors with access to a high-quality portfolio of healthcare real estate across regions including Australasia, Brazil, Germany, and Canada.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - )'s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$4.92 and traded as high as C$5.11. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.09, with a volume of 704,392 shares changing hands.

NorthWest Health Prop Real Est Inv Trust Price Performance

The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The firm has a market cap of C$1.26 billion, a PE ratio of -12.14, a P/E/G ratio of 0.74 and a beta of 1.53. The firm's fifty day simple moving average is C$4.96 and its two-hundred day simple moving average is C$4.92.

About NorthWest Health Prop Real Est Inv Trust

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.